Integrated genomic and proteomic analysis of signaling pathways in dendritic cell differentiation and maturation

Annals of the New York Academy of Sciences

Volumn 975, Issue , 2002, Pages 91-100

  Richards, John ^a   Le Naour, François ^a   Hanash, Samir ^a   Beretta, Laura ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Dendritic cell differentiation; Dendritic cell maturation; Genomic analysis; Proteomic analysis; Signaling pathways

Indexed keywords

ALPHA 1 ANTITRYPSIN; CCAAT ENHANCER BINDING PROTEIN; CD14 ANTIGEN; CD36 ANTIGEN; CD59 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE RECEPTOR CCR7; COMPLEMENT COMPONENT C5A RECEPTOR; DNA; GALECTIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; I KAPPA B ALPHA; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 4; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MACROPHAGE ELASTASE; MAJOR HISTOCOMPATIBILITY ANTIGEN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 4; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PRESENILIN 1; SEMAPHORIN; SYNDECAN; T6 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ANTIGEN PRESENTATION; CELL ADHESION; CELL DIFFERENTIATION; CELL MATURATION; CELL MOTILITY; CONFERENCE PAPER; DENDRITIC CELL; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENOMICS; HUMAN; IMMUNE RESPONSE; LIPID METABOLISM; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEOMICS; QUANTITATIVE ANALYSIS;

EID: 0036960169     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb05944.x     Document Type: Conference Paper

References (63)

1. BANCHEREAU, J. et al. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18: 767-811.
2. BANCHEREAU, J. & R.M. STEINMAN. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
3. CYSTER, J.G. 1999. Chemokines and cell migration in secondary lymphoid organs. Science 286: 2098-2102.
4. STEINMAN, R.M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9: 271-296.
5. STEINMAN, R.M. 2001. Dendritic cells and the control of immunity: enhancing the efficiency of antigen presentation. Mt. Sinai J. Med. 68: 106-166.
6. DHODAPKAR, M.V. et al. 2001. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 193: 233-238.
7. DHODAPKAR, M.V. et al. 1999. Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells. J. Clin. Invest. 104: 173-180.
8. RISSOAN, M.C. et al. 1999. Reciprocal control of T helper cell and dendritic cell differentiation [see comments]. Science 283: 1183-1186.
9. MALDONADO-LOPEZ, R. & M. MOSER. 2001. Dendritic cell subsets and the regulation of Th1/Th2 responses. Semin. Immunol. 13: 275-282.
10. LANZAVECCHIA, A. & F. SALLUSTO. 2001. The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics. Curr. Opin. Immunol. 13: 291-298.
11. STEINBRINK, K. et al. 1997. Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 159: 4772-4780.
12. CELLA, M. et al. 1999. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med. 189: 821-829.
13. KADOWAKI, N. et al. 2001. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194: 863-869.
14. HOFFMANN, J.A. et al. 1999. Phylogenetic perspectives in innate immunity. Science 284: 1313-1318.
15. JONULEIT, H. et al. 1997. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol. 27: 3135-3142.
16. LOCKHART, D.J. & E.A. WINZELER. 2000. Genomics, gene expression and DNA arrays. Nature 405: 827-836.
17. HANASH, S.M. 1998. Two-dimensional Gel Electrophoresis. In Gel Electrophoresis of Proteins: A Practical Approach. B.D. Hames & D. Rickwood, Eds.: 189-211. Oxford University Press. Oxford.
18. PANDEY, A. & M. MANN. 2000. Proteomics to study genes and genomes. Nature 405: 837-846.
19. LE NAOUR, F. et al. 2001. Profiling changes in gene expression during differentiation and maturation of monocyte-derived dendritic cells using both oligonucleotide microarrays and proteomics. J. Biol. Chem. 276: 17920-17931.
20. CHEN, Y., E. DOUGHERTY & M. BITTNER. 1997. Ratio-based decisions and the quantitative analysis of cDNA micro-array images. J. Biomed. Optics 2: 365.
21. BROWN, P.O. & D. BOTSTEIN. 1999. Exploring the new world of the genome with DNA microarrays. Nat. Genet. 21: 33-37.
22. DERISI, J. et al. 1996. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat. Genet. 14: 457-460.
23. KHAN, J. et al. 1998. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res. 58: 5009-5013.
24. SCHENA, M. 1996. Genome analysis with gene expression microarrays. Bioessays 18: 427-431.
25. SCHENA, M. et al. 1995. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270: 467-470.
26. SCHENA, M. et al. 1996. Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc. Natl. Acad. Sci. USA 93: 10614-10619.
27. TRENT, J.M. et al. 1997. Use of microgenomic technology for analysis of alterations in DNA copy number and gene expression in malignant melanoma. Clin. Exp. Immunol. 107(Suppl. 1): 33-40.
28. BAGNARD, D. et al. 1998. Semaphorins act as attractive and repulsive guidance signals during the development of cortical projections. Development 125: 5043-5053.
29. TRAHEY, M. & I.L. WEISSMAN. 1999. Cyclophilin C-associated protein: a normal secreted glycoprotein that down-modulates endotoxin and proinflammatory responses in vivo. Proc. Natl. Acad. Sci. USA 96: 3006-3011.
30. WISNIEWSKI, H.G. & J. VILCEK. 1997. TSG-6: an IL-1/TNF-inducible protein with anti-inflammatory activity. Cytokine Growth Factor Rev. 8: 143-156.
31. BAGGIOLINI, M., P. LOETSCHER & B. MOSER. 1995. Interleukin-8 and the chemokine family. Int. J. Immunopharmacol. 17: 103-108.
32. O'DONOVAN, N., M. GALVIN & J.G. MORGAN. 1999. Physical mapping of the CXC chemokine locus on human chromosome 4. Cytogenet. Cell Genet. 84: 39-42.
33. ASHKAR, S. et al. 2000. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 287: 860-864.
34. ULLRICH, A. et al. 1994. The secreted tumor-associated antigen 90K is a potent immune stimulator. J. Biol. Chem. 269: 18401-18407.
35. MITTRUCKER, H.W. et al. 1997. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 275: 540-543.
36. TANIGUCHI, T. et al. 2001. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19: 623-655.
37. MAMANE, Y. et al. 1999. Interferon regulatory factors: the next generation. Gene 237: 1-14.
38. LU, R. & P.M. PITHA. 2001. Monocyte differentiation to macrophage requires interferon regulatory factor 7. J. Biol. Chem. 276: 45491-45496.
39. GLATZ, J.F. & G.J. VAN DER VUSSE. 1996. Cellular fatty acid-binding proteins: their function and physiological significance. Prog. Lipid Res. 35: 243-282.
40. KLEMPT, M. et al. 1997. The heterodimer of the Ca2+-binding proteins MRP8 and MRP14 binds to arachidonic acid. FEBS Lett. 408: 81-84.
41. KERKHOFF, C. et al. 1999. The two calcium-binding proteins, S100A8 and S100A9, are involved in the metabolism of arachidonic acid in human neutrophils. J. Biol. Chem. 274: 32672-32679.
42. SIEGENTHALER, G. et al. 1997. A heterocomplex formed by the calcium-binding proteins MRP8 (S100A8) and MRP14 (S100A9) binds unsaturated fatty acids with high affinity. J. Biol. Chem. 272: 9371-9377.
43. FAERGEMAN, N.J. & J. KNUDSEN. 1997. Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signalling. Biochem. J. 323(Pt. 1): 1-12.
44. CLARKSON, M.R. et al. 1998. Leukotrienes and lipoxins: lipoxygenase-derived modulators of leukocyte recruitment and vascular tone in glomerulonephritis. Nephrol. Dial. Transplant. 13: 3043-3051.
45. KUHN, H. & B.J. THIELE. 1995. Arachidonate 15-lipoxygenase. J. Lipid Mediat. Cell Signal. 12: 157-170.
46. SIGAL, E. & D.J. CONRAD. 1994. Human 15-lipoxygenase: a potential effector molecule for interleukin-4. Adv. Prostaglandin Thromboxane Leukotriene Res. 22: 309-316.
47. HANASH, S.M. 2000. Biomedical applications of two-dimensional electrophoresis using immobilized pH gradients: current status. Electrophoresis 21: 1202-1209.
48. PATTERSON, S.D. 2000. Mass spectrometry and proteomics. Physiol. Genomics 2: 59-65.
49. COLACO, C.A. 1998. Towards a unified theory of immunity: dendritic cells, stress proteins and antigen capture. Cell. Mol. Biol. (Noisy-le-grand) 44: 883-890.
50. ARNOLD-SCHILD, D. et al. 1999. Cutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells. J. Immunol. 162: 3757-3760.
51. MANARA, G.C. et al. 1993. New insights suggesting a possible role of a heat shock protein 70-kD family-related protein in antigen processing/presentation phenomenon in humans. Blood 82: 2865-2871.
52. TODRYK, S. et al. 1999. Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake. J. Immunol. 163: 1398-1408.
53. DWORNICZAK, B. & M.E. MIRAULT. 1987. Structure and expression of a human gene coding for a 71 kd heat shock 'cognate' protein. Nucleic Acids Res. 15: 5181-5197.
54. THERY, C. et al. 1999. Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. J. Cell Biol. 147: 599-610.
55. JAATTELA, M. & D. WISSING. 1993. Heat-shock proteins protect cells from monocyte cytotoxicity: possible mechanism of self-protection. J. Exp. Med. 177: 231-236.
56. SAMALI, A. & T.G. COTTER. 1996. Heat shock proteins increase resistance to apoptosis. Exp. Cell Res. 223: 163-170.
57. MICHALAK, M. et al. 1999. Calreticulin: one protein, one gene, many functions. Biochem. J. 344 (Pt. 2): 281-292.
58. KRAUSE, K.H. & M. MICHALAK. 1997. Calreticulin. Cell 88: 439-443.
59. BASU, S. & P.K. SRIVASTAVA. 1999. Calreticulin, a peptide-binding chaperone of the endoplasmic reticulum, elicits tumor- and peptide-specific immunity. J. Exp. Med. 189: 797-802.
60. NAIR, S. et al. 1999. Calreticulin displays in vivo peptide-binding activity and can elicit CTL responses against bound peptides. J. Immunol. 162: 6426-6432.
61. PIKE, S.E. et al. 1998. Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth. J. Exp. Med. 188: 2349-2356.
62. PIKE, S.E. et al. 1999. Calreticulin and calreticulin fragments are endothelial cell inhibitors that suppress tumor growth. Blood 94: 2461-2468.
63. WATTS, C. 1997. Immunology. Inside the gearbox of the dendritic cell. Nature 388: 724-725.